Wear it pink on 24 October Wear pink. Raise money. Help make life-changing breast cancer research and support happen.
Home About us Media Breast Cancer Now media statements 215 results We respond to research about artificial sweeteners and breast cancer risk 24 Mar 2022 1 min read We respond to new data from major trial OlympiA shows adjuvant olaparib improved survival in patients 16 Mar 2022 1 min read We respond to NHS England's proposed new standards 09 Mar 2022 1 min read We respond to NHS England breast cancer waiting times: January 2022 10 Mar 2022 1 min read Breast Cancer Now responds to NICE provisional decision not to recommend pembrolizumab (Keytruda) in combination with chemotherapy (paclitaxel or nab-paclitaxel) 08 Mar 2022 3 min read Breast Cancer Now welcomes SMC decision to recommend Trodelvy for use on the NHS in Scotland 07 Mar 2022 3 min read We respond to NICE decision to recommend tucatinib with trastuzumab and capecitabine for routine use on the NHS 25 Feb 2022 2 min read We respond to today's NHSE Breast Screening Programme 2020-21 report 24 Feb 2022 2 min read We respond to the latest COVID-19 guidance 22 Feb 2022 1 min read We respond to a new study looking at breast pain and breast cancer 22 Feb 2022 1 min read We respond to 'The projected impact of the COVID-19 lockdown on breast cancer deaths in England due to the cessation of population screening: a national estimation’ 15 Feb 2022 1 min read We respond to NHS England breast cancer waiting times: December 2021 10 Feb 2022 1 min read Previous 1 ... 13 ... 18 Next
We respond to new data from major trial OlympiA shows adjuvant olaparib improved survival in patients 16 Mar 2022 1 min read
Breast Cancer Now responds to NICE provisional decision not to recommend pembrolizumab (Keytruda) in combination with chemotherapy (paclitaxel or nab-paclitaxel) 08 Mar 2022 3 min read
Breast Cancer Now welcomes SMC decision to recommend Trodelvy for use on the NHS in Scotland 07 Mar 2022 3 min read
We respond to NICE decision to recommend tucatinib with trastuzumab and capecitabine for routine use on the NHS 25 Feb 2022 2 min read
We respond to 'The projected impact of the COVID-19 lockdown on breast cancer deaths in England due to the cessation of population screening: a national estimation’ 15 Feb 2022 1 min read
